Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD
暂无分享,去创建一个
H. Peh | W. Wong | S. Johnston | I. Adcock | P. Barnes | W. E. Ho | A. Durham | Kazuhiro Ito | T. Kebadze | P. Mallia | L. Stanciu | O. Kon | S. Elkin | Hong Yong Peh | J. Aniscenko | S. Essilfie-Quaye | Ajerico del Rosario | J. Footitt | A. Telcian | Cheng Chang | M. Trujillo‐Torralbo | A. D. Rosario | Sarah L. Elkin | WS Fred Wong | S. L. Johnston | Sebastian L. Johnston | Sarah L Elkin | Sebastian L Johnston | Julia Aniscenko
[1] S. Johnston,et al. Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease☆ , 2014, Respiratory medicine.
[2] J. Walters,et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. , 2003, The Cochrane database of systematic reviews.
[3] S. Johnston,et al. Neutrophil adhesion molecules in experimental rhinovirus infection in COPD , 2013, Respiratory Research.
[4] P. Barnes. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. , 2013, The Journal of allergy and clinical immunology.
[5] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[6] S. Johnston,et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[7] F. Maltais,et al. TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial , 2012, Thorax.
[8] Christopher E Brightling,et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.
[9] C. Vogelmeier,et al. A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium , 2012, COPD.
[10] S. Johnston,et al. Viruses exacerbating chronic pulmonary disease: the role of immune modulation , 2012, BMC Medicine.
[11] M. Furue,et al. Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD , 2012, Journal of allergy.
[12] B. Fischer,et al. Pathogenic triad in COPD: oxidative stress, protease–antiprotease imbalance, and inflammation , 2011, International journal of chronic obstructive pulmonary disease.
[13] B. Cosío,et al. Mecanismos moleculares de inflamación durante las agudizaciones de la enfermedad pulmonar obstructiva crónica , 2011 .
[14] S. Johnston,et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. , 2011, American journal of respiratory and critical care medicine.
[15] A. Agustí,et al. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. , 2011, Archivos de bronconeumologia.
[16] I. Adcock,et al. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[17] Kazuhiro Ito,et al. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. , 2009, Biochemical and biophysical research communications.
[18] K. Kostikas,et al. Clinical, functional and biochemical changes during recovery from COPD exacerbations. , 2009, Respiratory medicine.
[19] A. Agustí,et al. Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD , 2009, Thorax.
[20] P. Calverley,et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.
[21] Hongwei Yao,et al. Future therapeutic treatment of COPD: Struggle between oxidants and cytokines , 2007, International journal of chronic obstructive pulmonary disease.
[22] S. Rennard,et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[23] R. Rodríguez-Roisín,et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. , 2011, The Cochrane database of systematic reviews.
[24] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[25] S. Johnston,et al. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study , 2006, Respiratory research.
[26] S. Johnston,et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.
[27] S. Rennard,et al. Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis. , 2006, American journal of respiratory cell and molecular biology.
[28] R. Djukanović,et al. Inflammatory cells in the airways in COPD , 2006, Thorax.
[29] I. Adcock,et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.
[30] R. Pauwels,et al. Matrix metalloproteinases in asthma and COPD. , 2005, Current opinion in pharmacology.
[31] N. Siafakas,et al. Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. , 2005, Chest.
[32] I. Adcock,et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.
[33] J. Roca,et al. Oxidative stress and airway inflammation in severe exacerbations of COPD , 2005, Thorax.
[34] L. Tamer,et al. N-acetylcysteine inhibits peroxynitrite-mediated damage in oleic acid-induced lung injury. , 2004 .
[35] M. Tabrizi,et al. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. , 2004, Chest.
[36] David E Levy,et al. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[38] I. Adcock,et al. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.
[39] P. Barnes,et al. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD , 2003, Thorax.
[40] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[41] N. Anthonisen,et al. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.
[42] T. Seemungal,et al. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease , 2001, Thorax.
[43] T. Seemungal,et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.
[44] K. Hirata,et al. Inhibition of bronchoprotective effects of beta2-adrenoceptor agonists by peroxynitrite in guinea pig airways. , 1999, American journal of respiratory and critical care medicine.
[45] E. Niki,et al. Peroxynitrite‐induced hemolysis of human erythrocytes and its inhibition by antioxidants , 1997, FEBS letters.
[46] K. Aben,et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[47] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.